These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17802962)

  • 1. [Turbidimetric assay of famotidine].
    Apostu M; Dorneanu V; Bibire N; Vieriu M
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):460-4. PubMed ID: 17802962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [UV spectrophotometric assay of famotidine in combination with picrolonic acid, picrolinate].
    Apostu M; Bibire N; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):422-5. PubMed ID: 16607813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of ninhydrin to spectrophotometric determination of famotidine in drug formulations.
    Rahman N; Kashif M
    Farmaco; 2003 Oct; 58(10):1045-50. PubMed ID: 14505737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extractional-spectrophotometric determination of famotidine in pharmaceutical formulations.
    Abu Zuhri AZ; Shubietah RM; Badah GM
    J Pharm Biomed Anal; 1999 Nov; 21(2):459-65. PubMed ID: 10704003
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of a rapid HPLC method for determination of famotidine in human plasma using a monolithic column.
    Zarghi A; Shafaati A; Foroutan SM; Khoddam A
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):677-80. PubMed ID: 15894447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrophotometric determination of H(2)-receptor antagonists via their oxidation with cerium(IV).
    Darwish IA; Hussein SA; Mahmoud AM; Hassan AI
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jan; 69(1):33-40. PubMed ID: 17442613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic spectrophotometric determination of famotidine in commercial dosage forms.
    Rahman N; Kashif M
    Anal Sci; 2003 Jun; 19(6):907-11. PubMed ID: 12834233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column.
    Helali N; Monser L
    J Sep Sci; 2008 Feb; 31(2):276-82. PubMed ID: 18172920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrofluorimetric analysis of famotidine in pharmaceutical preparations and biological fluids by derivatization with benzoin.
    Alamgir M; Khuhawar MY; Memon SQ; Hayat A; Zounr RA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 134():449-52. PubMed ID: 25033237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis.
    Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
    Electrophoresis; 2001 Aug; 22(13):2758-62. PubMed ID: 11545404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Validated Comparative Stability-Indicating Assay Method for Some H2-Receptor Antagonists.
    Ahmed S; Elshaboury SR; Mohamed NA; Farrag S
    J Chromatogr Sci; 2017 Sep; 55(8):818-831. PubMed ID: 28486578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and validation of a dissolution test for famotidine tablets using flow injection analysis.
    Tzanavaras PD; Verdoukas A; Balloma T
    J Pharm Biomed Anal; 2006 May; 41(2):437-41. PubMed ID: 16413732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analytical application of phosphotungstic acid complexes. Fabrication and characterisation of membrane selective electrodes for some H2 antihistaminics].
    Apostu M; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):856-9. PubMed ID: 20201281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of famotidine in an extemporaneously compounded oral liquid.
    Dentinger PJ; Swenson CF; Anaizi NH
    Am J Health Syst Pharm; 2000 Jul; 57(14):1340-2. PubMed ID: 10918924
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiometric determination of famotidine in pharmaceutical formulations.
    Ayad MM; Shalaby A; Abdellatef HE; Elsaid HM
    J Pharm Biomed Anal; 2002 Jun; 29(1-2):247-54. PubMed ID: 12062684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Turbidimetric determination of tenoxicam using molybdophosphoric acid].
    Muraraşu AE; Mândrescu M; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):249-54. PubMed ID: 20509311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of famotidine through charge-transfer complexation with chloranilic acid.
    Chukwurah BK; Ajali U
    Boll Chim Farm; 2001; 140(5):354-60. PubMed ID: 11680091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the stability of polymeric matrix tablets containing famotidine from the positron annihilation lifetime distributions of their physical mixtures.
    Szente V; Süvegh K; Marek T; Zelkó R
    J Pharm Biomed Anal; 2009 Apr; 49(3):711-4. PubMed ID: 19188038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of cefmetazole sodium and famotidine.
    Lee DK; Wong CY; Wang DP; Chang LC; Wit KH
    Am J Health Syst Pharm; 1996 Feb; 53(4):432, 442. PubMed ID: 8673667
    [No Abstract]   [Full Text] [Related]  

  • 20. [Liquid chromatography in pharmaceutical analysis: determination in tablets of famotidine, a new H2-antagonists].
    Ficarra R; Ficarra P; Calabrò ML
    Farmaco Prat; 1987 Nov; 42(11):307-12. PubMed ID: 2893743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.